CoChat

Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6)

Shafiq, Nusrat, Malhotra, Samir, Pandhi, Promila, Gupta, Monica, Kumar, Bhushan, Sandhu, Kanial · 2005 · International Journal of Dermatology
Cited by 79

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background Disordered differentiation and hyperproliferation of keratinocytes with inflammation are the hallmarks of psoriasis. Ligand activation of peroxisome proliferator receptor‐γ (a class of nuclear receptors) by thiazolidinediones can normalize the histologic features of psoriasis. Method In a 10‐week, double‐blind, randomized, placebo‐controlled, parallel‐group study, 70 patients with moderate to severe psoriasis received one of the following treatments: pioglitazone 15 mg, pioglitazone 30 mg or placebo. Efficacy was evaluated by observing the change in the psoriasis area and severity index (PASI) after 10 weeks of treatment. Results There was a dose‐dependent improvement in psoriasis. Median PASI scores at the end of 10 weeks were significantly reduced in the pioglitazone treatment groups as compared to the placebo‐treated group. The psoriasis lesions cleared in more than 40% of patients treated with pioglitazone as compared to 12.5% of those with placebo. The percentage reduction in mean PASI scores was 21.6%, 41.1% and 47.5% in the placebo, pioglitazone 15 mg, and 30 mg groups, respectively. No serious adverse events were detected. Conclusion This is the first report from a controlled trial demonstrating that pioglitazone could be considered as an efficacious and safe agent for the treatment of plaque psoriasis. The optimum dose and duration of pioglitazone therapy remain to be determined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-4632.2005.02504.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 79

Metadata

Authors
Shafiq, N., Malhotra, S., Pandhi, P., Gupta, M., Kumar, B., & Sandhu, K.
Venue
International Journal of Dermatology
Publisher
Wiley
Published
2005-03-30
Volume
44
Issue
4
Pages
328-333
ISSN
  • 0011-9059 (ISSN-L)
  • 1365-4632
OpenAlex
W2046429755
Cited by
79
References
6
FWCI
2.25
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6). https://app.cochat.ai/papers/10.1111/j.1365-4632.2005.02504.x
The paper
Shafiq, N., Malhotra, S., Pandhi, P., Gupta, M., Kumar, B., & Sandhu, K. (2005). Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6). International Journal of Dermatology. https://doi.org/10.1111/j.1365-4632.2005.02504.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.